Key Takeaways Genentech will more than double its Holly Springs plant investment to near $2B, expanding biomanufacturing.Roche aims to strengthen U.S. supply chains and scale biologics and metabolic therapies with automation.RHHBY expects the expanded Holly Springs facility to open by 2029, creating jobs and obesity drugs.Swiss pharma giant Roche’s (RHHBY) Genentech announced a significant expansion of its original investment in a new manufacturing facility in Holly Springs, NC.Genentech will more than doub ...